Evidence map›Paper›PMID 40947948›Full record

ArticleEuropean journal of clinical investigation2025

Ketone bodies and cancer risk in the general population: The prevention of renal and vascular end-stage disease (PREVEND) study.

Li Luo, Martine G E Knol, Lyanne M Kieneker, Bert van der Vegt, Stephan J L Bakker, Eke G Gruppen, Rudolf A de Boer, Joseph Pierre Aboumsallem, Margery A Connelly, Robin P F Dullaart and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Li LuoDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-7855-4669
Martine G E KnolDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Lyanne M KienekerDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Bert van der VegtDepartment of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Stephan J L BakkerDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Eke G GruppenDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Rudolf A de BoerDepartment of Cardiology, Thorax Center, Erasmus MC, Cardiovascular Institute, Rotterdam, The Netherlands.
Joseph Pierre AboumsallemDepartment of Cardiology, Thorax Center, Erasmus MC, Cardiovascular Institute, Rotterdam, The Netherlands.
Margery A ConnellyLabcorp, Morrisville, North Carolina, USA.
Robin P F DullaartDepartment of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0003-4520-1239
Ron T GansevoortDepartment of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Funding

China Scholarship Council 202008440376Dutch Heart Foundation 2001.005Dutch Kidney Foundation E.033European Research Council ERC CoG 818715the Dutch Governmentthe US National Institutes of HealthUniversity Medical Center Groningen
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancerketone bodiesmalignancypopulation‐based study

Identifiers

PMID40947948
PMCPMC12434450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.